Valuation: ResMed, Inc.

Capitalization 29.99B 25.48B 23.32B 22.01B 41.06B 2,833B 41.42B 277B 108B 1,361B 113B 110B 4,697B P/E ratio 2026 *
19.5x
P/E ratio 2027 * 17.6x
Enterprise value 29.08B 24.71B 22.61B 21.34B 39.81B 2,746B 40.16B 268B 105B 1,319B 109B 107B 4,554B EV / Sales 2026 *
5.15x
EV / Sales 2027 * 4.66x
Free-Float
75.61%
Yield 2026 *
1.18%
Yield 2027 * 1.3%
1 day-0.06%
1 week+0.85%
Current month-3.30%
1 month-9.31%
3 months-25.08%
6 months-17.79%
Current year-14.16%
1 week 203.92
Extreme 203.92
213.53
1 month 198.64
Extreme 198.64
232.32
Current year 198.64
Extreme 198.64
277.67
1 year 198.64
Extreme 198.64
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.28
Extreme 56.28
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Change 5d. change 1-year change 3-years change Capi.($)
-0.06%+0.85%-15.62%-10.54% 29.99B
-1.99%-0.90%+15.35%-13.03% 173B
-0.76%-1.69%-16.11%+49.25% 159B
-2.56%-2.28%-9.79%-27.22% 121B
-4.67%-4.55%-47.57%+1.58% 80.16B
-3.38%-4.79%+8.52%-9.85% 46.04B
-0.85%-3.56%-28.52%-40.48% 44.18B
+1.32%+15.63%+3.22%+28.32% 34.86B
-2.55%+0.96%+8.13%-9.21% 32.67B
+0.06%+1.31%-23.83%-43.92% 30.34B
Average -1.54%-0.27%-10.62%-7.51% 75.16B
Weighted average by Cap. -1.84%-1.16%-8.78%-1.03%

Financials

2026 *2027 *
Net sales 5.65B 4.8B 4.39B 4.15B 7.73B 534B 7.8B 52.11B 20.31B 256B 21.2B 20.75B 885B 6.08B 5.16B 4.73B 4.46B 8.32B 574B 8.39B 56.06B 21.86B 276B 22.81B 22.33B 952B
Net income 1.54B 1.31B 1.2B 1.13B 2.11B 146B 2.13B 14.24B 5.55B 70.03B 5.79B 5.67B 242B 1.7B 1.45B 1.32B 1.25B 2.33B 161B 2.35B 15.72B 6.13B 77.3B 6.39B 6.26B 267B
Net Debt -913M -775M -710M -670M -1.25B -86.18B -1.26B -8.42B -3.28B -41.4B -3.42B -3.35B -143B -1.64B -1.4B -1.28B -1.21B -2.25B -155B -2.27B -15.17B -5.91B -74.62B -6.17B -6.04B -258B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
08/05/26 206.76 $ -0.06% 993,580
07/05/26 206.89 $ -1.31% 1,315,641
06/05/26 209.64 $ +0.85% 1,444,862
05/05/26 207.88 $ -0.74% 1,849,981
04/05/26 209.43 $ +2.15% 2,483,799
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
206.76USD
Average target price
270.60USD
Spread / Average Target
+30.88%

Quarterly revenue - Rate of surprise